N-Methylpyrrolidone (NMP) is a toxic solvent that may pose serious side effects, leading regulators to indicate it will be banned from uses where safer alternatives are available, or there is no way to prevent excessive exposure.
Lawyers will select 25 Camp Lejeune lawsuits involving kidney cancer, bladder cancer, leukemia, non-Hodgkin's lymphoma or Parkinson's disease from a group of 100 eligible cases, which will be prepared for a series early test trials.
Judges overseeing the Camp Lejeune lawsuits will hear proposals from the U.S. government and plaintiff's leadership counsel over which illnesses and diseases should be selected for a third round of bellwether trials.
Women who suffered numerous miscarriages after exposure to Camp Lejeune water contamination say they have been ignored by efforts to compensate victims.
Researchers warn pregnant women with minor car accident injuries still face heightened risk of placental abruption, preterm labor and other complications.
The FDA decision to limit phthalates came after the agency decided there was not enough scientific data to support a full ban.
False pre-natal screening test results may have led some women to terminate healthy fetuses, the FDA warns.
The report found that advertising brochures gave expecting parents a false sense of security in the accuracy of prenatal blood tests.
Researchers suggest exposure to certain pollutants are more likely to cause miscarriage based on the gender of the unborn child.
A medical device sterilization facility knew about the leaks for years, but failed to warn local residents and federal regulators, the lawsuit claims
